Preliminary in vivo evaluation of [131I]-2-I-D-Phe as a potential radionuclide therapeutic agent in R1M-fluc rhabdomyosarcoma tumour bearing NuNu mice using bioluminescent imaging

Research output: Contribution to journalArticle

Abstract

BACKGROUND:

Carrier-added [(123)I]-2-iodo-D-phenylalanine (CA [(123)I]-2-I-D-Phe) was previously found to have a preferential retention in tumors with a high tumor background contrast in animal models. A previous human dosimetry study demonstrated a favorable biodistribution and radiation burden in human subjects.

AIM:

The aim of this study was to investigate the potential of CA [(131)I]-2-I-D-Phe as an agent for radionuclide therapy.

METHODS:

Sixty (60) nude athymic mice were inoculated subcutaneously with firefly luciferase-transduced R1M rhabdomyosarcoma cells. The mice in the therapy group were injected intravenously (i.v.) with 148 MBq [(131)I]-2-I-D-Phe (432 GBq/mmol) in kit solution. Controls were injected with kit solution without radioactivity, with physiological saline, or with 148 MBq [(131)I](-) in physiological saline. Tumor growth was quantified using bioluminescent imaging and caliper measurements.

RESULTS:

[(131)I]-2-I-D-Phe clearly reduced tumor growth in the treated mice compared with the control groups. A tumor growth-rate reduction of at least 33% was found for mice receiving a therapeutic dose. There were no serious adverse side-effects of the therapy.

CONCLUSIONS:

In conclusion, i.v. injection of CA 148 MBq [(131)I]-2-I-D-Phe specifically reduces tumor growth in athymic nude mice without relevant side-effects on the animals' health.
Original languageEnglish
Pages (from-to)225-231
Number of pages7
JournalCancer Biotherapy and Radiopharmaceuticals
Volume25
Publication statusPublished - 1 Apr 2010

Keywords

  • radionuclide

Fingerprint

Dive into the research topics of 'Preliminary in vivo evaluation of [131I]-2-I-D-Phe as a potential radionuclide therapeutic agent in R1M-fluc rhabdomyosarcoma tumour bearing NuNu mice using bioluminescent imaging'. Together they form a unique fingerprint.

Cite this